NCT03948802View on ClinicalTrials.gov

Evaluation of IL-33 in Patients With the Acute Ischemic Stroke

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

March 6, 2024

Conditions
Ischemic Stroke
Interventions
DIAGNOSTIC_TEST

Interleukine 33 test in blood plasma

ELISA test for Interleukin 33

Trial Locations (1)

86-168

Jan Biziel University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University, Bydgoszcz

All Listed Sponsors
lead

Jan Biziel University Hospital No 2 in Bydgoszcz

OTHER

NCT03948802 - Evaluation of IL-33 in Patients With the Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter